Catalyst Wire Dossier Catalyst Wire Dossier

GPC3/B7-H3 CAR-NK cells

CAR-NK cells targeting GPC3 and B7-H3 · Beijing Biotech
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPC3/B7-H3 CAR-NK cells, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC [Phase 1, Phase 2]

See pricing